 UiPath is not profitable. Growth has stalled. Shares arent cheap. Momentum is negative. The macroeconomic environment seems detrimental to any prospect of short-term rerating. A sell rating on PATH seems like the easiest and safest choice. We argue the contrarian case and rate the stock a strong buy. 